Labstract aims to bring together scientists and technology providers to catalyse ever more creative and efficient ways to promote drug discovery.

Labstract was founded in 2006 by Dr Suki Klair. Suki has 15 years' experience as a medicinal chemist - most recently in structure-based drug discovery, high-throughput synthesis & automation and has a keen interest in new and emerging bioscience technologies.

Labstract hopes to create an environment where these new technologies are accessible to small and growing biotech companies and where the biotech companies themselves have the opportunity to liase closely with technology providers.